Company Overview and News

99
[Opinion] Move Aside Lithium – Vanadium Is The New Super-Metal

2018-10-12 oilvoice
By James Burgess The lithium ride was a great one. Cobalt, too. All they needed was their Elon Musk moment, which came in the form of the Nevada battery gigafactory. The next Elon Musk moment won't be about lithium at all—or even cobalt. It will be for an element that takes everything electric to its revolutionary finish line: Vanadium. The one moment that will change everything … and that moment may be near.
PBEGF FTI.WI FMC TSLA CCJ UBMCF GM BLDP

99
[Opinion] Move Aside Lithium – Vanadium Is The New Super-Metal

2018-10-12 oilvoice
By James Burgess The lithium ride was a great one. Cobalt, too. All they needed was their Elon Musk moment, which came in the form of the Nevada battery gigafactory. The next Elon Musk moment won't be about lithium at all—or even cobalt. It will be for an element that takes everything electric to its revolutionary finish line: Vanadium. The one moment that will change everything … and that moment may be near.
PBEGF FTI.WI FMC TSLA CCJ UBMCF GM BLDP

101
Move Aside Lithium – Vanadium Is The New Super-Metal

2018-10-10 oilprice - 2
James Burgess studied Business Management at the University of Nottingham. He has worked in property development, chartered surveying, marketing, law, and accounts. He has also…
FTI.WI FMC TSLA CCJ UBMCF GM BLDP

35
alphaDIRECT Advisors Discusses Ballard Power Systems and Its Work in the Area of Unmanned Vehicles

2018-10-10 accesswire
SAN FRANCISCO, CA / ACCESSWIRE / October 10, 2018 / alphaDIRECT Advisors (ADA), a division of EnergyTech Investor, LLC and a Publishing and Investor Intelligence firm, announced today that Shawn Severson, Founding Partner, conducted an interview with Ballard Power Systems, Inc. (NASDAQ/TSX: BLDP) to discuss its work in the area of unmanned vehicles, including UAVs or drones. The interview is with Phil Robinson, Vice President, Unmanned Systems.
BLDP

37
Anglo American’s venture capital spin-off seeks investors to join in the hunt for fuel cell energy start-ups

2018-09-30 scmp - 2
AP Ventures, with US$200 million worth of assets under management, launches new fund to target investments in renewable energy-related projects
AAUKF 2338 WEICF JMPLY 3993 AAL JMPLF NGLOY WEICY BLDP

36
Ballard Power Systems (BLDP) Presents at Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow

2018-09-06 seekingalpha - 1
The following slide deck was published by Ballard Power Systems, Inc. in conjunction with this event.
BLDP

41
Ballard Power Systems (BLDP) Catches Eye: Stock Jumps 9%

2018-09-05 zacks
Ballard Power Systems Inc. (BLDP - Free Report) was a big mover last session, as the company saw its shares rise 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.94 to $3.54 in the past one-month time frame. The move came after the company announced the divestiture of some of its non-core assets.
KEM HDS BLDP

63
Ballard Power (BLDP) to Divest Non-Core Assets in Protonex

2018-09-03 zacks - 1
Ballard Power Systems, Inc. (BLDP - Free Report) has entered into a definitive agreement with Revision Military Ltd., a private U.S.-based company, to sell certain non-core assets of its subsidiary, Protonex, with regard to its Power Manager business. The company will receive a total of $16 million in cash as sale consideration. However, it will still retain certain assets related to fuel cell propulsion systems for military and commercial unmanned vehicles.
BLD 2338 FCELB WEICF DDAIF PLUG FCEL BLDP WEICY

65
FuelCell (FCEL) Sells Turnkey Project to American Electric

2018-08-31 zacks - 2
FuelCell Energy, Inc. (FCEL - Free Report) recently announced that it has sold a turnkey project to AEP OnSite Partners a subsidiary of American Electric Power Company, Inc. (AEP - Free Report) . This project will supply clean power and heat to Trinity College under a multi-year power purchase agreement (PPA). Details of the Project The project company sold by FuelCell Energy is a 1.4-megawatt (MW) fuel cell power plant, located at Trinity College in Connecticut.
FCELB AEP PLUG FCEL BLDP

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to BLDP / Ballard Power Systems, Inc. on message board site Silicon Investor.

Ballard Power -world leader zero-emission PEM fuel cells Ballard Power -world leader zero-emission PEM fuel cells Ballard Power -world leader zero-emission PEM fuel cells Ballard Power (BLDPF) - The Holy Grail Ballard Power (BLDPF) - The Holy Grail Ballard Power (BLDPF) - The Holy Grail
CUSIP: 058586108